Obalon Therapeutics
Earnings Date & Report
Last updated:
Obalon Therapeutics’s last earnings date was on 12 May 2021. It reported its quarterly earnings per share (EPS) reaching -$0.44.
Obalon Therapeutics stock Earnings report, Estimates & History
| 2016-11-11 | -0.34 | -5.46 |
|---|---|---|
| 2017-02-23 | -0.34 | -0.51 |
| 2017-05-10 | -0.41 | -0.47 |
| 2017-08-02 | -0.44 | -0.46 |
| 2017-11-03 | -4.52 | -5.5 |
| 2018-03-05 | -4.55 | -6 |
| 2018-05-10 | -5.03 | -7.1 |
| 2018-08-02 | -5.1 | -5.7 |
| 2018-11-02 | -4.77 | -3.5 |
| 2019-02-22 | -3.6 | -3.9 |
| 2019-05-10 | -3.7 | -3.6 |
| 2019-07-24 | -2.43 | -2.5 |
| 2019-11-08 | -2.14 | -0.61 |
| 2020-02-27 | -0.58 | -0.64 |
| 2020-06-19 | -0.51 | -0.68 |
| 2020-07-30 | -0.3 | -0.54 |
| 2020-11-06 | -0.07 | -0.2 |
| 2021-03-12 | -0.06 | -0.17 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Obalon Therapeutics stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 12 May 2021 | N/A | N/A | -$0.44 | N/A | N/A | |
| 12 Mar 2021 | Missed | -$0.06 | -$0.17 | N/A | 61K | |
| 6 Nov 2020 | Missed | -$0.07 | -$0.2 | 37.71K | 44K | |
| 30 Jul 2020 | Missed | -$0.3 | -$0.54 | 521.97K | 703K | |
| 19 Jun 2020 | Missed | -$0.51 | -$0.68 | 527.25K | 780K | |
| 27 Feb 2020 | Missed | -$0.58 | -$0.64 | 713.21K | 787K | |
| 8 Nov 2019 | Beat | -$2.14 | -$0.61 | 1.16M | 333K | Earnings Call Transcript |
| 24 Jul 2019 | Missed | -$2.43 | -$2.5 | 375.19K | 386K | Earnings Call Transcript |
| 10 May 2019 | Beat | -$3.7 | -$3.6 | 1.82M | 1.77M | |
| 22 Feb 2019 | Missed | -$3.6 | -$3.9 | 1.87M | 2.03M | Earnings Call Transcript |
| 2 Nov 2018 | Beat | -$4.77 | -$3.5 | 4.07M | 2.98M | Earnings Call Transcript |
| 2 Aug 2018 | Missed | -$5.1 | -$5.7 | 2.44M | 2.73M | |
| 10 May 2018 | Missed | -$5.03 | -$7.1 | 956.40K | 1.34M | |
| 5 Mar 2018 | Missed | -$4.55 | -$6 | 2.79M | 3.69M | |
| 3 Nov 2017 | Missed | -$4.52 | -$5.5 | 2.29M | 2.78M | Earnings Call Transcript |
| 2 Aug 2017 | Missed | -$0.44 | -$0.46 | 1.87M | 1.96M | Earnings Call Transcript |
| 10 May 2017 | Missed | -$0.41 | -$0.47 | 1.28M | 1.47M | Earnings Call Transcript |
| 23 Feb 2017 | Missed | -$0.34 | -$0.51 | 513.33K | 772K | |
| 11 Nov 2016 | Missed | -$0.34 | -$5.46 | 9.78M | 773K | |
| 5 Oct 2016 | N/A | N/A | N/A | N/A | 779K | |
Obalon Therapeutics Earnings report FAQs
When is Obalon Therapeutics's next Earnings date?
The company has not set the next earnings date yet. The latest Obalon Therapeutics's earnings date was on 19 Jun 2020.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.